Kristen Fread

Kristen Fread has worked in the biotechnology field since 2012, starting as an Undergraduate Research Assistant at Virginia Tech. Kristen then went on to pursue a PhD at the University of Virginia from 2015 to 2019. In 2019, they were a NIH Biotechnology Training Grant Fellow at Editas Medicine. Most recently, they are a Scientist I, Cell Differentiation at Clade Therapeutics, which they started in 2022.

Kristen Fread attended Virginia Tech from 2011 to 2015, where they earned a Bachelor's Degree in Biochemistry with minors in Chemistry and Spanish. Kristen then attended the University of Virginia from 2015 to 2022, where they are currently pursuing a Doctor of Philosophy in Biomedical/Medical Engineering.